NEW YORK (GenomeWeb News) – Molecular Diagnostics firm GeneNews today said that its first-quarter loss was C$1.3 million (US$1.3 million), or C$.01 per share.

Results for the three months ended March 31 compare to a net loss of C$1.1 million, or C$.02 per share, a year ago.

The Toronto-based company did not disclose other financial information for the quarter, and its quarterly financial filing was not yet available on the SEDAR website, which provides public securities documents for Canadian companies.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Genome Research this week: mitochondrial and nuclear gene fusions in cancer, role of genomic imprinting in tissue-specific gene expression, and more.

Maria Freire from the Foundation for the NIH calls for "politically popular pledges of support" for the NIH to turn into support for increased funding for the agency.

A Thomson Reuters analysis indicates that the life sciences, rather than the tech sector, are increasingly driving global innovation.

The White House says ethical discussions about genome editing of the human germline are needed.